Emerald Health Therapeutics, Inc. (CVE:EMH – Get Free Report)’s share price dropped 3.8% on Tuesday . The stock traded as low as C$0.25 and last traded at C$0.26. Approximately 384,329 shares were traded during trading, a decline of 40% from the average daily volume of 644,760 shares. The stock had previously closed at C$0.27.
Emerald Health Therapeutics Stock Down 3.8 %
The company’s 50 day moving average price is C$0.26 and its two-hundred day moving average price is C$0.26. The company has a quick ratio of 2.61, a current ratio of 2.97 and a debt-to-equity ratio of 35.45. The stock has a market cap of C$52.28 million and a P/E ratio of -0.37.
About Emerald Health Therapeutics
Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015.
Featured Stories
- Five stocks we like better than Emerald Health Therapeutics
- Business Services Stocks Investing
- Hasbro’s Management Made All the Right Calls This Quarter
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- What is the Euro STOXX 50 Index?
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for Emerald Health Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emerald Health Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
